RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-2452185f7ece0b1eGRADE VERY_LOW
guayusa constituents — blood pressure
direction BENEFIT · dose 650 mg · duration UNSPECIFIED
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
LOWextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
MODERATEnumeric
1bound studies
Bound studies (1 shown of 1)
STU-237da627f66bf535RCT · HUMAN · 2023 · RoB SOME_CONCERNS
3 endpoints
Quantitative observations
observation p ≤ 0.05 | p ≤ 0.05 · failed extraction
observation 650 mg · validated
observation p ≤ 0.05 · validated
Opposition screen
SCREEN · 2 candidates considered · 1 bound as opposing
SYNTHESIS SYN-8f1ab051ba2a89 — outcome SYNTHESIS_INAPPROPRIATE · BENEFIT ×1 · not_assessed_quantitatively · 1 members
PROVENANCE → crf:10.3390/nu15245018 · PKG 5a60be3ff12d724a…
CLAIM · CLM-333e0ec53613495dGRADE VERY_LOW
guayusa constituents — mood
direction BENEFIT · dose 650 mg · duration UNSPECIFIED
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
LOWextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
MODERATEnumeric
1bound studies
Bound studies (1 shown of 1)
STU-237da627f66bf535RCT · HUMAN · 2023 · RoB SOME_CONCERNS
3 endpoints
Quantitative observations
observation p ≤ 0.05 | p ≤ 0.05 · failed extraction
observation 650 mg · validated
observation p ≤ 0.05 · validated
Opposition screen
SCREEN · 3 candidates considered · 2 bound as opposing
SYNTHESIS SYN-dafa6e3540c1d0 — outcome SYNTHESIS_INAPPROPRIATE · BENEFIT ×1 · not_assessed_quantitatively · 1 members
PROVENANCE → crf:10.3390/nu15245018 · PKG 5a60be3ff12d724a…
Bounded preview — representative records only. The full release ships 7 claims and 12 observations.